jueves, 17 de septiembre de 2009

La marca "contraataca"...

Although generic medications have long been touted for their cost-effectiveness, concerns have been raised about the effect of generic substitution in everyday practice, differences in bioequivalence standards for FDA approval, and recent manufacturing recalls. (Ver...)




No hay comentarios: